Researchers have developed a personalized blood test that may offer a faster, less invasive way to track high-grade glioma progression.

Mayo Clinic researchers have identified a potential new way to monitor the progression of high-grade gliomas, one of the most ...

Mayo Clinic researchers have identified a potential new way to monitor the progression of high-grade gliomas , one of the ...

A new study reveals blood tests can predict melanoma recurrence by detecting circulating tumor DNA. Research shows 80% of ...

Breast cancer is becoming increasingly treatable, but in some cases the disease can resurface even decades after a patient ...

Somewhere in the body of a patient, a small clump of cells, growing undetected, has begun to form a tumor. It has yet to ...

Stratham's Erin McBride, who survived a brain tumor while pregnant, says she "appreciates every moment" as she prepares to ...

The tool analyzes results from standard tests of organ function, tumor burden, and inflammation to predict whether lymphoma patients will respond to treatment.

Physicians classify brain tumors and determine treatment options, in part, by the genes they express. According to World Health Organization standards, the abnormal activation of oncogene FOXR2 only ...

Scientists have implicated the FOXR2 gene in previously unassociated brain tumor types, with implications for diagnosis, prognosis and treatment.

Study findings suggested that assessing ctDNA levels was as good or better at predicting recurrence than experimental tests ...